Suchergebnisse - "Curtin, Nicola"

PubPharm (127)

91

Visualization of a DNA-PK/PARP1 complex

enthalten in: Nucleic acids research | 2012

von Spagnolo, L. | Barbeau, J. | Curtin, N. | +2

92

Targeting the S and G2 checkpoint to treat cancer

enthalten in: Drug discovery today | 2012

von Chen, T. | Stephens, P. | Middleton, F. | +1

93

Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination

enthalten in: Cancer chemotherapy and pharmacology | 2012

von Tavecchio, M. | Munck, J. | Cano, C. | +2

94

The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice

enthalten in: Molecular cancer therapeutics | 2011

von Ali, M. | Kamjoo, M. | Thomas, H. | +6

95

Understanding what students bring to the classroom : moderators of the effects of diversity courses on student attitudes

enthalten in: Cultural diversity & ethnic minority psychology | 2011

von Cole, E. | Case, K. | Rios, D. | +1

96

Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301

enthalten in: European journal of cancer (Oxford, England : 1990) | 2011

von Thomas, H. | Wang, L. | Roche, C. | +7

97

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

enthalten in: Nature medicine | 2011

von Johnson, N. | Li, Y. | Walton, Z. | +12

CommentIn: Nat Rev Clin Oncol. 2011 Sep;8(9):508. - PMID 21769119

98

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

enthalten in: The Biochemical journal | 2011

von Zaremba, T. | Thomas, H. | Cole, M. | +3

99

Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination

enthalten in: Cancer chemotherapy and pharmacology | 2011

von Tavecchio, M. | Munck, J. | Cano, C. | +2

100

Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination

enthalten in: Cancer chemotherapy and pharmacology | 2011

von Tavecchio, M. | Munck, J. | Cano, C. | +2

[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[13]